Skip to main content
Livermore
Livermore
ZHEN

Qube Research & Technologies Ltd

SEC CIK
0001729829
Latest filing
Aug 14, 2026

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by Qube Research & Technologies Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
14
Since Q1 2021
Holdings of VRTX by Qube Research & Technologies Ltd, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−3,998−100.0%Sold outHolders
Q1 20263,998$1.79M<0.1%+3,998NewHolders
Q4 20250$00.0%−51,382−100.0%Sold outHolders
Q3 202551,382$20.1M<0.1%+45,701+804.5%AddedHolders
Q2 20255,681$2.53M<0.1%−28,865−83.6%ReducedHolders
Q1 202534,546$16.7M<0.1%+34,546NewHolders
Q4 20240$00.0%−131,156−100.0%Sold outHolders
Q3 2024131,156$61.0M0.1%−322,217−71.1%ReducedHolders
Q2 2024453,373$212.5M0.4%−105,163−18.8%ReducedHolders
Q1 2024558,536$233.5M0.4%+93,511+20.1%AddedHolders
Q4 2023465,025$189.2M0.4%+45,916+11.0%AddedHolders
Q3 2023419,109$145.7M0.4%+339,462+426.2%AddedHolders
Q2 202379,647$28.0M0.1%+79,647NewHolders
Q1 20230$00.0%−427,529−100.0%Sold outHolders
Q4 2022427,529$123.5M0.7%+330,619+341.2%AddedHolders
Q3 202296,910$28.1M0.2%+96,910NewHolders
Q4 20210$00.0%−43,583−100.0%Sold outHolders
Q3 202143,583$7.91M0.1%+43,583NewHolders
Q2 20210$00.0%−28,845−100.0%Sold outHolders
Q1 202128,845$6.20M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.